微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 70.51% | -2.25% | 0.43% | 20/133 | 51.33% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 70.21% | -1.88% | -0.67% | 21/133 | 51.45% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 70.68% | -1.53% | -1.98% | 21/133 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 72.11% | 1.75% | -0.03% | 18/133 | 52.13% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 72.13% | 4.07% | 0.81% | 22/133 | 53.25% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 71.55% | 4.05% | -0.31% | 22/133 | 53.3% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 71.78% | 1.81% | 1.28% | 26/133 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 70.87% | 4.04% | 2.24% | 24/133 | 53.09% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 69.31% | 2% | 0.79% | 28/133 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 68.77% | 5.39% | -2.45% | 31/133 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 70.5% | 2% | 3.5% | 24/133 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 68.12% | 5.31% | 4.39% | 33/133 | 53.59% | 三友医疗 | 90.18% | 行业排名> |
| 2022-06-30 | 65.25% | 3.25% | 0.88% | 42/133 | 54.78% | 三友医疗 | 90.14% | 行业排名> |
| 2021-12-31 | 64.68% | 6.45% | 6.45% | 51/133 | 57.29% | 三友医疗 | 90.29% | 行业排名> |
| 2020-12-31 | 60.76% | -2.12% | -3.85% | 66/133 | 59.59% | 三友医疗 | 90.73% | 行业排名> |
| 2020-06-30 | 63.2% | 2% | 1.8% | 51/133 | 59.94% | 三友医疗 | 90.5% | 行业排名> |
| 2019-12-31 | 62.08% | 2% | 2% | 56/133 | 56.37% | 三友医疗 | 90.29% | 行业排名> |